Molecular Partners Ag MOLN
NASDAQ MOLN
$4.18 -0.17 (-3.76%)
As of: Sep 10, 2026 · 9:51 AM EDT

Molecular Partners Ag (MOLN) Interest Coverage Ratio (2020 - 2026)

Molecular Partners Ag's (MOLN) quarterly Interest Coverage Ratio came in at 1.24 in Q2 2026, up 24879.18% year-over-year from N/an in Q2 2025, and up 1.1% quarter-over-quarter from 1.22 in Q1 2026.

Analysis

Molecular Partners Ag (MOLN) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Interest Coverage Ratio for 7 consecutive years, with 1.24 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 24879.18% year-over-year to 1.24 in Q2 2026; TTM through Jun 2026 was 133.18, a 1705.51% increase from a year earlier, with the FY2025 full-year figure at 11.51, up 100.71% from the prior year.
  • Interest Coverage Ratio was 1.24 for Q2 2026 at Molecular Partners Ag, up from 1.22 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 887.56 in Q2 2024 and troughed at 9706.79 in Q4 2022.
  • A 5-year average of 852.14 and a median of 0.92 in 2022 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio sank 47641.96% in 2024 and surged 24879.18% in 2026, its largest moves.
  • Over 5 years, Interest Coverage Ratio stood at 9706.79 in 2022, then soared by 100.15% to 14.31 in 2023, then slumped by 47641.96% to 6805.16 in 2024, then soared by 103.32% to 225.89 in 2025, then tumbled by 99.45% to 1.24 in 2026.
  • The last three Interest Coverage Ratio figures came in at 1.24 (Q2 2026), 1.22 (Q1 2026), and 225.89 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 5.22
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 117.59
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 493.00
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 2.82
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Molecular Partners Ag 156.54 Mn 156.54 Mn - -1,235.55
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24
Mar 31, 2026 1.22
Dec 31, 2025 225.89
Sep 30, 2025 0.08
Jun 30, 2025 0.00
Mar 31, 2025 0.01
Dec 31, 2024 -6,805.16
Sep 30, 2024 0.01
Jun 30, 2024 887.56
Mar 31, 2024 1.59
Dec 31, 2023 14.31
Sep 30, 2023 1.23
Jun 30, 2023 13.32
Mar 31, 2023 0.03
Dec 31, 2022 -9,706.79
Sep 30, 2022 0.13
Jun 30, 2022 26.11
Mar 31, 2022 0.61
Dec 31, 2021 597.83
Sep 30, 2021 0.10